from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2346c/esxO

LFCtreatmentdescriptionclass of inhibitor

0.209

Amikacinug/mL Amikacintranslation

0.237

Cap5-10ug/mL Capreomycintranslation

-0.722

Rox10-50 ug/mL Roxithromycintranslation

0.201

SM2-5 ug/mL Streptomycintranslation

-0.062

Tet5-10 ug/mL Tetracyclinetranslation

-2.299

Rif0.2-5ug/mL Rifampicintranscription

-1.668

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.116

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.190

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.317

CPZ10-50 ug/mL Chlorpromazinerespiration

0.162

Clofazimine10-13 ug/mL Clofaziminerespiration

0.091

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.261

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.778

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.206

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.226

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.759

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.176

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.261

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.116

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.005

KCN5-20 ug/mL Potassium cyaniderespiration

-0.103

NaN30.2-2 mM Sodium aziderespiration

0.378

Nigericin50 uM Nigericinrespiration

-0.864

TRC10-150 ug/mL Triclosanrespiration

0.244

TRZ10-25 ug/mL Thioridazinerespiration

-1.999

Valinomycin0.5-10 uM Valinomycinrespiration

0.301

ZnSO42 mM ZnSO4respiration

-0.273

menadione6-10 ug/mL Menadionerespiration

1.095

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.516

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.075

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.202

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.022

NRP_1Non-replicating persistence stage 1dosRassociated

0.872

Amp0.2mg/mL AmpicillincellWall

0.298

Cephalexin20-100 ug/mL CephalexincellWall

0.096

Cerulenin0.32-5 ug/mL CerulenincellWall

0.725

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.738

EMB10-20 ug/mL EthambutolcellWall

0.727

Eta12-40 ug/mL EthionamidecellWall

0.698

INH0.2-0.4 ug/mL IsoniazidcellWall

0.176

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.539

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.245

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.564

BZA0.12 mg/mL BenzamidearomaticAmides

-0.830

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.918

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.479

H2O24 mM hydrogen peroxideDNAdamaging

0.121

Levo10 ug/mL LevofloxacinDNAdamaging

0.835

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.150

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.092

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.638

UVUV-irradiationDNAdamaging

-0.714

ARP41-4 ug/mL Antitubercular compound ARP4?

0.949

Antimycin12.5-50 ug/mL Antimycin A?

0.248

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.738

PA_110-50 ug/mL Antitubercular compound PA-1?

0.728

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.392

PA8240.2-2 ug/mL PA-824?

-0.203

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.036

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.191

Verapamil50 uM Verapamil?

0.471

mercaptoethanol2 mM 2-Mercaptoethanol?

0.215

methoxatin10-20 ug/mL Methoxatin?